News Italian decision sets up launch of Oncopeptides' Pepaxti Oncopeptides hopes to reignite growth in multiple myeloma drug Pepaxti after getting reimbursement approval in Italy.
News Pfizer offers $60m to settle prescriber kickback claims Pfizer has paid $60m to settle US government allegations that its Biohaven unit made improper payments to prescribers of its migraine drug Nurtec ODT.
News UnitedHealth names CEO to replace slain Thompson UnitedHealth has appointed company veteran Tim Noel as CEO of its UnitedHealthcare insurance unit, after the murder last month of Brian Thompson.
News Purdue and Sacklers agree new $7.4bn opioid settlement Purdue Pharma and the Sackler family who own the company have proposed a new $7.4 billion settlement to resolve thousands of opioid-related lawsuits.
News US/EU regulators start review of Biogen's high-dose Spinraza Biogen's new high-dose version of SMA drug Spinraza has started regulatory reviews - but can it help return the drug to growth?
News Date set for RFK Jr's health secretary confirmation hearing A Senate hearing on Robert F Kennedy Jr's nomination as HHS Secretary is set for 29th January, with opposition to Trump's pick seemingly growing.
News Sanofi gives up on amlitelimab in atopic dermatitis Sanofi has stopped development of anti-OX40L drug amlitelimab in atopic dermatitis, a major blow to what was once viewed as a 'pipeline-in-a-product'.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
